EOLS PEER ANALYSIS

Evolus Inc — metric-by-metric comparison with peers and the industry median

EOLSEvolus Inc

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

EOLSIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	EOLS	HLN	TLRY	DEVA	GENIL	ECILC	Ind. Median
P/E	—	31.38●	—	—	46.82	—	21.55
P/B	-15.72●	1.98	0.31	0.49	3.47	0.77	1.91
EV/EBITDA	—	19.20	—	6.51●	14.07	32.83	12.18
P/S	1.50	3.95	0.56●	0.68	1.86	4.88	2.13

Financial Health
Metric	EOLS	HLN	TLRY	DEVA	GENIL	ECILC	Ind. Median
Current Ratio	2.04	0.92	2.79●	2.00	1.33	1.73	2.22
Debt/Equity	-573.0%●	52.3%	20.4%	23.1%	41.0%	5.9%	46.3%
NetDebt/EBITDA	-8.20●	3.50	-0.07	0.89	1.10	-0.10	1.24

Profitability
Metric	EOLS	HLN	TLRY	DEVA	GENIL	ECILC	Ind. Median
Net Margin	-14.4%	12.6%●	-158.8%	-4.4%	4.0%	-3.6%	4.0%
ROE	—	6.3%	-63.6%	-3.6%	8.7%●	-0.6%	6.4%
ROA	-20.0%	3.2%	-49.7%	-2.5%	4.8%●	-0.5%	3.4%
EBITDA Margin	-4.6%	25.2%●	-156.2%	12.0%	14.3%	14.8%	18.2%

Growth + Dividend
Metric	EOLS	HLN	TLRY	DEVA	GENIL	ECILC	Ind. Median
Rev. Growth	9.6%	-26.7%	3.8%	7.7%	16.3%●	-2.3%	7.5%
NI Growth	—	-14.2%	—	—	146.6%●	—	5.0%
Div. Yield	—	2.0%	—	0.0%	0.0%	2.7%●	2.0%
Payout	—	40.0%	—	0.0%	0.0%	-365.1%	0.8%

Valuation
Metric	EOLS	EBS	ORGO	IRWD	SIGA	AMPH	Ind. Median
P/E	—	—	—	7.29●	12.98	11.77	21.55
P/B	-15.72●	0.90	0.84	-3.43	1.73	1.21	1.91
EV/EBITDA	—	5.71	8.00	5.42	4.29●	6.92	12.18
P/S	1.50	0.69	0.62●	2.06	2.80	1.29	2.13

Financial Health
Metric	EOLS	EBS	ORGO	IRWD	SIGA	AMPH	Ind. Median
Current Ratio	2.04	4.29●	3.53	1.41	3.25	3.85	2.22
Debt/Equity	-573.0%●	109.7%	18.6%	-275.1%	0.4%	88.7%	46.3%
NetDebt/EBITDA	-8.20●	2.68	-0.57	1.82	-5.27	2.05	1.24

Profitability
Metric	EOLS	EBS	ORGO	IRWD	SIGA	AMPH	Ind. Median
Net Margin	-14.4%	-1.3%	-0.1%	28.3%●	21.6%	11.0%	4.0%
ROE	—	-1.6%	-0.1%	—	11.0%●	10.4%	6.4%
ROA	-20.0%	-0.6%	-0.1%	26.8%●	8.7%	4.8%	3.4%
EBITDA Margin	-4.6%	22.8%	7.3%	57.3%●	29.3%	26.6%	18.2%

Growth + Dividend
Metric	EOLS	EBS	ORGO	IRWD	SIGA	AMPH	Ind. Median
Rev. Growth	9.6%	-29.9%	11.9%	13.8%●	-22.1%	-1.1%	7.5%
NI Growth	—	—	—	—	-58.2%	-44.1%●	5.0%
Div. Yield	—	—	3.6%	—	16.5%●	—	2.0%
Payout	—	—	-4,093.3%	—	213.6%	—	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on EOLS

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.